HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
Go back to HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment| BIOTELEMETRY (NASDAQ: BEAT) | Delayed: 0.72 +0.29 (67.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $21.68 | |||
| Open | $0.75 | 52 Week Low | $8.74 | |||
| Day High | $0.94 | P/E | N/A | |||
| Day Low | $0.66 | EPS | $-0.46 | |||
| Volume | 257,605,398 | |||||



